BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

  May 29, 2026

   · 

  1 min read
• Press Releases

  Vimy Pharma Files Health Canada Submission for Generic Ozempic® (Semaglutide)

  May 29, 2026

   · 

  1 min read
• Press Releases

  Sysmex America Introduces Next Generation XR-Series™ Hematology Solution for Clinical Laboratories

  May 29, 2026

   · 

  2 min read
• Press Releases

  Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference

  May 29, 2026

   · 

  1 min read
• Press Releases

  Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

  May 29, 2026

   · 

  11 min read
• Press Releases

  FDA approves label expansion, cementing TREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage

  May 29, 2026

   · 

  14 min read
• Press Releases

  Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

  May 29, 2026

   · 

  11 min read
• Press Releases

  Phanes Therapeutics Announces Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting

  May 29, 2026

   · 

  4 min read
• Press Releases

  IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

  May 29, 2026

   · 

  19 min read
• Press Releases

  Immunohistochemistry Market to Reach $5.14 Billion by 2030, Driven by Rising Cancer Diagnostics and Adoption of Standardized Kits

  May 29, 2026

   · 

  1 min read